结局变量,N,治疗效应系数,标准误,95%CI下限,95%CI上限,P值,R²,显著,控制变量,解释
ALT变化,265,-0.5503770307908691,1.4734353077118276,-3.4518150882584138,2.3510610266766756,0.7090571906321677,0.03397582568680235,否,基线值+年龄+性别+是否合并脂肪肝,控制混杂因素后，治疗组ALT变化无显著减少0.55单位
AST变化,265,-0.2767725094957087,1.065726129416064,-2.375363696052306,1.8218186770608888,0.7952990247895424,0.02994081464176579,否,基线值+年龄+性别+是否合并脂肪肝,控制混杂因素后，治疗组AST变化无显著减少0.28单位
肝硬度变化,196,-0.2590452787561972,0.4698681210981911,-1.18587338944499,0.6677828319325957,0.582065608653794,0.45508386709728177,否,基线值+年龄+性别+是否合并脂肪肝,控制混杂因素后，治疗组肝硬度变化无显著减少0.26单位
